Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 28.71x is 73% below its estimated 2-year average of 107.60x, near the low end of its estimated 2-year range (3.28x–440.02x).
As of 2026-10-06T17:17:52.666Z. 262.83% above its estimated 12-month average of 7.91x.
Calculation as of: 2026-10-06T17:17:52.666Z.
Quote observation: 2026-10-06T17:15:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c423fd58fa010454b187d960c45a161fd4b2d9bd49eac7b4b936e7343169081d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
28.71x
EV/EBITDA RATIO AVG TTM
7.91x
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+262.83%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.75x
median of 207 covered companies
CURRENT VS SECTOR MEDIAN
+82.29%
vs the sector median at left
PTC Therapeutics, Inc.
Market Cap
$5.28B
EV/EBITDA Ratio
28.71x
TTM Avg
7.91x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.26B
EV/EBITDA Ratio
12.53x
TTM Avg
12.96x
3Y Avg
13.18x
5Y Avg
14.62x
Market Cap
$5.22B
EV/EBITDA Ratio
N/A
TTM Avg
12.99x
3Y Avg
275.14x
5Y Avg
275.14x
Market Cap
$5.07B
EV/EBITDA Ratio
16.14x
TTM Avg
15.97x
3Y Avg
19.93x
5Y Avg
21.74x
Market Cap
$5.06B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.53B
EV/EBITDA Ratio
30.73x
TTM Avg
33.01x
3Y Avg
33.01x
5Y Avg
33.01x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | $5.28B | 28.71x | 7.91x | N/A | N/A |
| Sotera Health Company (SHC)vs › | $5.26B | 12.53x | 12.96x | 13.18x | 14.62x |
| Doximity, Inc. (DOCS)vs › | $5.31B | 23.86x | 26.05x | 37.20x | 51.94x |
| CRISPR Therapeutics AG (CRSP)vs › | $5.22B | N/A | 12.99x | 275.14x | 275.14x |
| Cogent Biosciences, Inc. (COGT)vs › | $5.16B | N/A | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 16.14x | 15.97x | 19.93x | 21.74x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.06B | N/A | N/A | N/A | N/A |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.53B | 30.73x | 33.01x | 33.01x | 33.01x |
| RadNet, Inc. (RDNT)vs › | $5.53B | 21.71x | 24.95x | 22.12x | 17.84x |
| Erasca, Inc. (ERAS)vs › | $5.00B | N/A | N/A | N/A | N/A |
At 28.7, EV/EBITDA is near its estimated 2-year median — higher than 58% of readings in its estimated 2-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 2-year low
3.3
median
8.1
estimated 2-year high
440.0
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 32.08x |
| 2026-10-02 | 31.98x |
| 2026-10-01 | 32.34x |
| 2026-09-30 | 32.69x |
| 2026-09-29 | 32.78x |
| 2026-09-28 | 33.32x |
| 2026-09-25 | 31.56x |
| 2026-09-24 | 31.35x |
| 2026-09-23 | 31.38x |
| 2026-09-22 | 33.32x |
| 2026-09-21 | 32.94x |
| 2026-09-18 | 33.00x |
| 2026-09-17 | 34.41x |
| 2026-09-16 | 34.19x |
| 2026-09-15 | 33.15x |
| 2026-09-14 | 33.60x |
| 2026-09-11 | 33.37x |
| 2026-09-10 | 34.08x |
| 2026-09-09 | 34.18x |
| 2026-09-08 | 34.85x |
| 2026-09-04 | 35.11x |
| 2026-09-03 | 36.24x |
| 2026-09-02 | 36.45x |
| 2026-09-01 | 35.79x |
| 2026-08-31 | 35.24x |
| 2026-08-28 | 35.54x |
| 2026-08-27 | 36.46x |
| 2026-08-26 | 36.93x |
| 2026-08-25 | 37.35x |
| 2026-08-24 | 36.06x |
| 2026-08-21 | 35.39x |
| 2026-08-20 | 35.77x |
| 2026-08-19 | 37.46x |
| 2026-08-18 | 36.90x |
| 2026-08-17 | 37.03x |
| 2026-08-14 | 36.40x |
| 2026-08-13 | 36.54x |
| 2026-08-12 | 36.90x |
| 2026-08-11 | 37.47x |
| 2026-08-10 | 37.97x |
| 2026-08-07 | 37.26x |
| 2026-08-06 | 35.94x |
| 2026-08-05 | 35.06x |
| 2026-08-04 | 35.00x |
| 2026-08-03 | 34.47x |
| 2026-07-31 | 34.42x |
| 2026-05-07 | 7.73x |
| 2026-05-06 | 7.92x |
| 2026-05-05 | 7.78x |
| 2026-05-04 | 7.82x |
| 2026-05-01 | 7.79x |
| 2026-04-30 | 7.79x |
| 2026-04-29 | 7.74x |
| 2026-04-28 | 8.25x |
| 2026-04-27 | 8.16x |
| 2026-04-24 | 8.07x |
| 2026-04-23 | 8.10x |
| 2026-04-22 | 8.31x |
| 2026-04-21 | 8.29x |
| 2026-04-20 | 8.44x |
| 2026-04-17 | 8.45x |
| 2026-04-16 | 8.38x |
| 2026-04-15 | 8.55x |
| 2026-04-14 | 8.50x |
| 2026-04-13 | 8.27x |
| 2026-04-10 | 8.11x |
| 2026-04-09 | 8.31x |
| 2026-04-08 | 8.34x |
| 2026-04-07 | 8.19x |
| 2026-04-06 | 8.13x |
| 2026-04-02 | 8.03x |
| 2026-04-01 | 8.12x |
| 2026-03-31 | 8.06x |
| 2026-03-30 | 7.84x |
| 2026-03-27 | 7.88x |
| 2026-03-26 | 7.96x |
| 2026-03-25 | 7.94x |
| 2026-03-24 | 7.74x |
| 2026-03-23 | 7.91x |
| 2026-03-20 | 7.81x |
| 2026-03-19 | 7.97x |
| 2026-03-18 | 7.96x |
| 2026-03-17 | 8.00x |
| 2026-03-16 | 7.93x |
| 2026-03-13 | 7.73x |
| 2026-03-12 | 7.63x |
| 2026-03-11 | 7.84x |
| 2026-03-10 | 8.10x |
| 2026-03-09 | 8.09x |
| 2026-03-06 | 7.58x |
| 2026-03-05 | 7.63x |
| 2026-03-04 | 7.72x |
| 2026-03-03 | 7.73x |
| 2026-03-02 | 7.90x |
| 2026-02-27 | 8.07x |
| 2026-02-26 | 8.06x |
| 2026-02-25 | 8.03x |
| 2026-02-24 | 8.14x |
| 2026-02-23 | 8.28x |
| 2026-02-20 | 8.29x |
| 2026-02-19 | 7.21x |
| 2026-02-18 | 7.10x |
| 2026-02-17 | 7.13x |
| 2026-02-13 | 7.16x |
| 2026-02-12 | 7.29x |
| 2026-02-11 | 7.32x |
| 2026-02-10 | 7.45x |
| 2026-02-09 | 7.67x |
| 2026-02-06 | 7.72x |
| 2026-02-05 | 7.47x |
| 2026-02-04 | 7.64x |
| 2026-02-03 | 7.74x |
| 2026-02-02 | 7.74x |
| 2026-01-30 | 7.81x |
| 2026-01-29 | 7.91x |
| 2026-01-28 | 7.82x |
| 2026-01-27 | 7.81x |
| 2026-01-26 | 7.89x |
| 2026-01-23 | 7.78x |
| 2026-01-22 | 7.88x |
| 2026-01-21 | 7.82x |
| 2026-01-20 | 7.55x |
| 2026-01-16 | 7.48x |
| 2026-01-15 | 7.82x |
| 2026-01-14 | 8.00x |
| 2026-01-13 | 7.80x |
| 2026-01-12 | 8.03x |
| 2026-01-09 | 8.03x |
| 2026-01-08 | 7.96x |
| 2026-01-07 | 8.00x |
| 2026-01-06 | 7.94x |
| 2026-01-05 | 7.95x |
| 2026-01-02 | 7.94x |
| 2025-12-31 | 7.86x |
| 2025-12-30 | 7.88x |
| 2025-12-29 | 8.04x |
| 2025-12-26 | 8.14x |
| 2025-12-24 | 8.12x |
| 2025-12-23 | 8.05x |
| 2025-12-22 | 8.18x |
| 2025-12-19 | 8.14x |
| 2025-12-18 | 7.71x |
| 2025-12-17 | 7.75x |
| 2025-12-16 | 7.80x |
| 2025-12-15 | 7.89x |
| 2025-12-12 | 7.82x |
| 2025-12-11 | 7.80x |
| 2025-12-10 | 7.66x |
| 2025-12-09 | 7.59x |
| 2025-12-08 | 7.96x |
| 2025-12-05 | 8.00x |
| 2025-12-04 | 8.06x |
| 2025-12-03 | 7.84x |
| 2025-12-02 | 8.13x |
| 2025-12-01 | 8.21x |
| 2025-11-28 | 8.94x |
| 2025-11-26 | 8.97x |
| 2025-11-25 | 8.61x |
| 2025-11-24 | 8.28x |
| 2025-11-21 | 8.13x |
| 2025-11-20 | 7.91x |
| 2025-11-19 | 7.82x |
| 2025-11-18 | 7.94x |
| 2025-11-17 | 7.82x |
| 2025-11-14 | 7.79x |
| 2025-11-13 | 7.75x |
| 2025-11-12 | 7.75x |
| 2025-11-11 | 7.63x |
| 2025-11-10 | 7.48x |
| 2025-11-07 | 7.41x |
| 2025-11-06 | 7.50x |
| 2025-11-05 | 7.41x |
| 2025-11-04 | 6.25x |
| 2025-11-03 | 6.27x |
| 2025-10-31 | 6.31x |
| 2025-10-30 | 6.29x |
| 2025-10-29 | 6.21x |
| 2025-10-28 | 6.22x |
| 2025-10-27 | 6.18x |
| 2025-10-24 | 6.11x |
| 2025-10-23 | 6.15x |
| 2025-10-22 | 6.12x |
| 2025-10-21 | 6.19x |
| 2025-10-20 | 6.31x |
| 2025-10-17 | 6.06x |
| 2025-10-16 | 6.15x |
| 2025-10-15 | 6.33x |
| 2025-10-14 | 6.08x |
| 2025-10-13 | 6.07x |
| 2025-10-10 | 6.09x |
| 2025-10-09 | 6.07x |
| 2025-10-08 | 5.91x |
| 2025-10-07 | 5.85x |
| 2025-10-06 | 5.94x |
| 2025-10-03 | 6.00x |
| 2025-10-02 | 5.76x |
| 2025-10-01 | 5.65x |
| 2025-09-30 | 5.58x |
| 2025-09-29 | 5.51x |
| 2025-09-26 | 5.33x |
| 2025-09-25 | 5.21x |
| 2025-09-24 | 5.39x |
| 2025-09-23 | 5.50x |
| 2025-09-22 | 5.53x |
| 2025-09-19 | 5.49x |
| 2025-09-18 | 5.74x |
| 2025-09-17 | 5.51x |
| 2025-09-16 | 5.41x |
| 2025-09-15 | 5.33x |
| 2025-09-12 | 5.55x |
| 2025-09-11 | 5.54x |
| 2025-09-10 | 5.26x |
| 2025-09-09 | 5.27x |
| 2025-09-08 | 5.12x |
| 2025-09-05 | 5.15x |
| 2025-09-04 | 5.23x |
| 2025-09-03 | 4.97x |
| 2025-09-02 | 4.65x |
| 2025-08-29 | 4.32x |
| 2025-08-28 | 4.37x |
| 2025-08-27 | 4.37x |
| 2025-08-26 | 4.34x |
| 2025-08-25 | 4.32x |
| 2025-08-22 | 4.45x |
| 2025-08-21 | 4.28x |
| 2025-08-20 | 4.27x |
| 2025-08-19 | 4.35x |
| 2025-08-18 | 4.37x |
| 2025-08-15 | 4.27x |
| 2025-08-14 | 4.26x |
| 2025-08-13 | 4.20x |
| 2025-08-12 | 3.90x |
| 2025-08-11 | 3.69x |
| 2025-08-08 | 3.91x |
| 2025-08-07 | 4.40x |
| 2025-08-06 | 4.52x |
| 2025-08-05 | 4.49x |
| 2025-08-04 | 4.62x |
| 2025-08-01 | 4.61x |
| 2025-07-31 | 4.61x |
| 2025-07-30 | 4.47x |
| 2025-07-29 | 4.28x |
| 2025-07-28 | 3.70x |
| 2025-07-25 | 3.75x |
| 2025-07-24 | 3.93x |
| 2025-07-23 | 4.02x |
| 2025-07-22 | 3.94x |
| 2025-07-21 | 4.11x |
| 2025-07-18 | 4.08x |
| 2025-07-17 | 4.19x |
| 2025-07-16 | 4.14x |
| 2025-07-15 | 4.10x |
| 2025-07-14 | 4.30x |
| 2025-07-11 | 4.19x |
| 2025-07-10 | 4.30x |
| 2025-07-09 | 4.21x |
| 2025-07-08 | 4.09x |
| 2025-07-07 | 4.12x |
| 2025-07-03 | 4.25x |
| 2025-07-02 | 4.26x |
Showing the most recent 260 of 436 data points. The chart above shows the full history.
